Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$0.31 - $0.55 $8,590 - $15,241
-27,712 Reduced 30.45%
63,301 $32,000
Q1 2023

May 15, 2023

BUY
$0.32 - $1.88 $29,124 - $171,104
91,013 New
91,013 $30,000
Q1 2022

May 16, 2022

SELL
$1.63 - $3.63 $191,060 - $425,490
-117,215 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$2.25 - $4.11 $90,245 - $164,847
-40,109 Reduced 25.49%
117,215 $264,000
Q3 2021

Nov 15, 2021

BUY
$2.71 - $5.9 $426,348 - $928,211
157,324 New
157,324 $636,000

About Vivos Therapeutics, Inc.


  • Ticker VVOS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 23,012,100
  • Market Cap $78.2M
  • Description
  • Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment alternatives for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers the Vivos System, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dent...
More about VVOS
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.